COVID-19 is having a devastating impact on people and its consequences will be lasting and profound. 3D printing forms part of the urgent solution, such as production of ventilators, but also the longer term opportunity to prevent this ever happening again.


BiologIC brings for the first time the potential for a standard, universal platform (a “bio-computer”) that provides horizontal integration across the life science industry: in bio-surveillance (detecting new viruses), helping read the DNA of the virus, researching vaccines more quickly and scaling up production. 

These improvements will significantly help new virus prevention and detection and also make it much quicker to identify vaccines and manufacture them rapidly at scale. Data can also be fed back to centralised teams and the platform can be rapidly evolved as needed.

3D printed system

In addition, because virology is also a cornerstone technique of molecular biology, the same standardised platforms also have the potential to be operated in research laboratory environments in many applications around the world.

Because the BiologIC platform is a 3D printed and fully enclosed system, it allows decentralised manufacturing that helps solve all these problems not only in centralised labs, but also at the point of need anywhere in the field.

Rapid production

It is reasonable to expect countries and corporates to take greater control of their critical infrastructure, and 3D printing is set to become a key enabler of these new supply chains.  This will allow rapid production of a new and powerful platform customised to the particular virus and produced on demand.

Whilst the platform technology is under development, it is progressing rapidly and has significant potential to help prevent, detect, research, test and treat this threat to our way of life.